Avidity Partners Management LP Bristol Myers Squibb CO Transaction History
Avidity Partners Management LP
- $885 Million
- Q4 2024
A detailed history of Avidity Partners Management LP transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Avidity Partners Management LP holds 215,000 shares of BMY stock, worth $12 Million. This represents 1.37% of its overall portfolio holdings.
Number of Shares
215,000
Previous 263,000
18.25%
Holding current value
$12 Million
Previous $13.6 Million
10.65%
% of portfolio
1.37%
Previous 0.84%
Shares
2 transactions
Others Institutions Holding BMY
# of Institutions
2,751Shares Held
1.57BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$10.6 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.86 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.36 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.31 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.37 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $119B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...